These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12026524)

  • 41. New diagnostic criteria and management of acute kidney injury.
    Wong F; Angeli P
    J Hepatol; 2017 Apr; 66(4):860-861. PubMed ID: 27984175
    [No Abstract]   [Full Text] [Related]  

  • 42. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatorenal syndrome].
    Pŭrvanov P
    Khirurgiia (Sofiia); 2002; 58(2):34-9. PubMed ID: 12515019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatorenal syndrome: a critical update.
    Wadei HM
    Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatorenal syndrome.
    Bataller R; Ginès P; Guevara M; Arroyo V
    Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.
    Mulkay JP; Louis H; Donckier V; Bourgeois N; Adler M; Deviere J; Le Moine O
    Acta Gastroenterol Belg; 2001; 64(1):15-9. PubMed ID: 11322061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenesis and management of the hepatorenal syndrome.
    Laffi G; La Villa G; Gentilini P
    Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664
    [No Abstract]   [Full Text] [Related]  

  • 48. Cross-talk between the liver, heart and kidney - another piece in the puzzle.
    Krag A; Gluud LL
    J Gastrointestin Liver Dis; 2014 Jun; 23(2):119-21. PubMed ID: 24949601
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
    Meltzer J; Brentjens TE
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal insufficiency in the patient with chronic liver disease.
    Bozanich NK; Kwo PY
    Clin Liver Dis; 2015 Feb; 19(1):45-56. PubMed ID: 25454296
    [No Abstract]   [Full Text] [Related]  

  • 52. Pathogenesis of the hepatorenal syndrome.
    Davidson EW; Dunn MJ
    Annu Rev Med; 1987; 38():361-72. PubMed ID: 2953301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatorenal syndrome. Its clinical, paraclinical, therapeutic, evolutive and prognostic aspects].
    Pospai D; Oproiu C; Oproiu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(6):561-73. PubMed ID: 2895951
    [No Abstract]   [Full Text] [Related]  

  • 54. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacological treatment of ascites and hepatorenal syndrome].
    Gülberg V; Gerbes AL
    Dtsch Med Wochenschr; 2003 Feb; 128(8):375-7. PubMed ID: 12594623
    [No Abstract]   [Full Text] [Related]  

  • 56. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatorenal syndrome: definition, pathophysiology, clinical features and management.
    Bataller R; Sort P; Ginès P; Arroyo V
    Kidney Int Suppl; 1998 May; 66():S47-53. PubMed ID: 9573573
    [No Abstract]   [Full Text] [Related]  

  • 58. Terlipressin avoids hemodialysis in the treatment of refractory hyperkalemia associated with renal dysfunction in cirrhosis.
    Kalambokis G; Milionis H; Elisaf M; Tsianos EV
    Am J Med; 2005 Sep; 118(9):1051-2. PubMed ID: 16164896
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Physiopathology of refractory ascites and the hepatorenal syndrome].
    Arroyo V
    Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.